Patient-reported Outcomes (PROs): Putting the Patient Perspective in Patient-centered Outcomes Research

Patient-centered outcomes research (PCOR) aims to improve care quality and patient outcomes by providing information that patients, clinicians, and family members need regarding treatment alternatives, and emphasizing patient input to inform the research process. PCOR capitalizes on available data sources and generates new evidence to provide timely and relevant information and can be conducted using prospective data collection, disease registries, electronic medical records, aggregated results from prior research, and administrative claims. Given PCOR’s emphasis on the patient perspective, methods to incorporate patient-reported outcomes (PROs) are critical. PROs are defined by the US Food and Drug Administration as “Any report coming directly from patients… about a health condition and its treatment.” However, PROs have not routinely been collected in a way that facilitates their use in PCOR. Electronic medical records, disease registries, and administrative data have only rarely collected, or been linked to, PROs. Recent technological developments facilitate the electronic collection of PROs and linkage of PRO data, offering new opportunities for putting the patient perspective in PCOR. This paper describes the importance of and methods for using PROs for PCOR. We (1) define PROs; (2) identify how PROs can be used in PCOR and the critical role of electronic data methods for facilitating the use of PRO data in PCOR; (3) outline the challenges and key unanswered questions that need to be addressed for the routine use of PROs in PCOR; and (4) discuss policy and research interventions to accelerate the integration of PROs with clinical data.

[1]  Albert W Wu,et al.  Feasibility and value of PatientViewpoint: a web system for patient‐reported outcomes assessment in clinical practice , 2013, Psycho-oncology.

[2]  Sarah Schmiege,et al.  Comparative Effectiveness Research , 2013, Western journal of nursing research.

[3]  Albert W Wu,et al.  The Use of Patient-reported Outcomes (PRO) Within Comparative Effectiveness Research: Implications for Clinical Practice and Health Care Policy , 2012, Medical care.

[4]  J. Newman,et al.  Copyright and open access at the bedside. , 2011, The New England journal of medicine.

[5]  Corneel Coens,et al.  Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. , 2011, Journal of the National Cancer Institute.

[6]  Daniel J Buysse,et al.  The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. , 2010, Journal of clinical epidemiology.

[7]  A. Wu,et al.  Adding the patient perspective to comparative effectiveness research. , 2010, Health affairs.

[8]  Sydney M. Dy,et al.  Needs assessments can identify scores on HRQOL questionnaires that represent problems for patients: an illustration with the Supportive Care Needs Survey and the QLQ-C30 , 2010, Quality of Life Research.

[9]  Mark Harniss,et al.  The development of a clinical outcomes survey research application: Assessment CenterSM , 2010, Quality of Life Research.

[10]  N. Devlin,et al.  Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision-Making , 2010 .

[11]  N. Aaronson,et al.  Use of patient-reported outcomes in clinical practice , 2009, The Lancet.

[12]  Roxanne Jensen,et al.  PatientViewpoint: a website for patient-reported outcomes assessment , 2009, Quality of Life Research.

[13]  J. Greenhalgh The applications of PROs in clinical practice: what are they, do they work, and why? , 2009, Quality of Life Research.

[14]  Matthias Rose,et al.  Logistics of collecting patient-reported outcomes (PROs) in clinical practice: an overview and practical examples , 2009, Quality of Life Research.

[15]  C. Gotay,et al.  The prognostic significance of patient-reported outcomes in cancer clinical trials. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  D. Osoba,et al.  Lessons learned in the assessment of health-related quality of life: selected examples from the National Cancer Institute of Canada Clinical Trials Group. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Albert W. Wu,et al.  Issues in the design of Internet-based systems for collecting patient-reported outcomes , 2007, Quality of Life Research.

[18]  Thomas A. Cavanaugh,et al.  To tell the truth , 1997, Journal of General Internal Medicine.

[19]  U. S. Department of Health and Human Services FDA Cen Research,et al.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance , 2006, Health and quality of life outcomes.

[20]  A. Wu,et al.  Health Status Assessment: Completing the Clinical Database , 2006, Journal of General Internal Medicine.

[21]  C. Acquadro,et al.  Patient-Reported Outcome and Quality of Life Instruments Database (PROQOLID): Frequently asked questions , 2005, Health and quality of life outcomes.

[22]  R. Hiatt,et al.  Cancer outcomes research and the arenas of application. , 2004, Journal of the National Cancer Institute. Monographs.

[23]  D. Cella,et al.  Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials , 1992, Quality of Life Research.

[24]  Outcomes Assessment in Cancer: Applications of item response theory to improve health outcomes assessment: developing item banks, linking instruments, and computer-adaptive testing , 2004 .

[25]  J. Unützer,et al.  National Institutes of Health State-of-the-Science Conference Statement , 2005, Journal of palliative medicine.

[26]  J. Chmiel,et al.  Health-related quality of life among people with HIV disease: Results from the Multicenter AIDS Cohort Study , 2004, Quality of Life Research.

[27]  N. Leidy,et al.  Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[28]  J. Unützer,et al.  National Institutes of Health State-of-the-Science Conference Statement: Symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002. , 2004, Journal of the National Cancer Institute. Monographs.

[29]  Gordon H Guyatt,et al.  Methods to explain the clinical significance of health status measures. , 2002, Mayo Clinic proceedings.

[30]  J. R. Scotti,et al.  Available From , 1973 .

[31]  J. L. Dahl,et al.  The new JCAHO pain assessment standards: implications for the medical director. , 2000, Journal of the American Medical Directors Association.

[32]  A. Wu,et al.  Quality of life assessment comes of age in the era of highly active antiretroviral therapy. , 2000, AIDS.

[33]  J. Pater Quality of life and pharmacoeconomics in clinical trials , 1996 .

[34]  M. Barry,et al.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. , 1992, The Journal of urology.

[35]  M. Schumacher,et al.  Assessment of quality of life in clinical trials. , 1991, Statistics in medicine.

[36]  C. Moinpour,et al.  Quality of life end points in cancer clinical trials: review and recommendations. , 1989, Journal of the National Cancer Institute.

[37]  G. Guyatt,et al.  Measuring disease-specific quality of life in clinical trials. , 1986, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[38]  M. Liang,et al.  Measuring function and health status in rheumatic disease clinical trials. , 1983, Clinics in rheumatic diseases.